192 related articles for article (PubMed ID: 19711095)
1. Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD.
Laveneziana P; Palange P; Ora J; Martolini D; O'Donnell DE
Eur J Appl Physiol; 2009 Dec; 107(6):633-43. PubMed ID: 19711095
[TBL] [Abstract][Full Text] [Related]
2. Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD.
Laveneziana P; Valli G; Onorati P; Paoletti P; Ferrazza AM; Palange P
Eur J Appl Physiol; 2011 Feb; 111(2):225-34. PubMed ID: 20852881
[TBL] [Abstract][Full Text] [Related]
3. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the exercise ventilatory compensation point by the analysis of the relationship between minute ventilation and heart rate.
Onorati P; Martolini D; Ora J; Valli G; Fedeli A; Palange P
Eur J Appl Physiol; 2008 Sep; 104(1):87-94. PubMed ID: 18553100
[TBL] [Abstract][Full Text] [Related]
5. Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD.
Puente-Maestu L; García de Pedro J; Martínez-Abad Y; Ruíz de Oña JM; Llorente D; Cubillo JM
Chest; 2005 Aug; 128(2):651-6. PubMed ID: 16100150
[TBL] [Abstract][Full Text] [Related]
6. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
7. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
[TBL] [Abstract][Full Text] [Related]
8. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.
Palange P; Valli G; Onorati P; Antonucci R; Paoletti P; Rosato A; Manfredi F; Serra P
J Appl Physiol (1985); 2004 Nov; 97(5):1637-42. PubMed ID: 15234959
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-acting dual bronchodilator therapy on exercise tolerance, dynamic hyperinflation, and dead space during constant work rate exercise in COPD.
Stringer WW; Porszasz J; Cao M; Rossiter HB; Siddiqui S; Rennard S; Casaburi R
J Appl Physiol (1985); 2021 Jun; 130(6):2009-2018. PubMed ID: 33914661
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance.
Elbehairy AF; Ciavaglia CE; Webb KA; Guenette JA; Jensen D; Mourad SM; Neder JA; O'Donnell DE;
Am J Respir Crit Care Med; 2015 Jun; 191(12):1384-94. PubMed ID: 25826478
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
[TBL] [Abstract][Full Text] [Related]
13. The oxygen uptake kinetic response to moderate intensity exercise in overweight and non-overweight children.
Potter CR; Zakrzewski JK; Draper SB; Unnithan VB
Int J Obes (Lond); 2013 Jan; 37(1):101-6. PubMed ID: 22907694
[TBL] [Abstract][Full Text] [Related]
14. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Voduc N; Fitzpatrick M; Webb KA
Eur Respir J; 2004 Jul; 24(1):86-94. PubMed ID: 15293609
[TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases.
Ferrazza AM; Martolini D; Valli G; Palange P
Respiration; 2009; 77(1):3-17. PubMed ID: 19145106
[TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction.
Steinshamn S; Sandsund M; Sue-Chu M; Bjermer L
Scand J Med Sci Sports; 2002 Aug; 12(4):211-7. PubMed ID: 12199869
[TBL] [Abstract][Full Text] [Related]
17. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
18. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
O'Donnell DE; Sciurba F; Celli B; Mahler DA; Webb KA; Kalberg CJ; Knobil K
Chest; 2006 Sep; 130(3):647-56. PubMed ID: 16963658
[TBL] [Abstract][Full Text] [Related]
19. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
Peters MM; Webb KA; O'Donnell DE
Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
